Glycated albumin modulates platelet susceptibility to flow induced activation and aggregation

References

• Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K, Kalea AZ, Lu Y, Rosario RH, Oruganti S, et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in ApoE-/- mice. J Clin Invest 2008; 118: 183–194
   PubMed Web of Science ®Google Scholar
• Chibber R, Molinatti PA, Kohner EM. Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. Cell Mol Biol (Noisy-Le-Grand) 1999; 45: 47–57
   PubMedGoogle Scholar
• Monnier VM, Stevens VJ, Cerami A. Maillard reactions involving proteins and carbohydrates in vivo: Relevance to diabetes mellitus and aging. Prog Food Nutr Sci 1981; 5: 315–327
   PubMedGoogle Scholar
• Cho SJ, Roman G, Yeboah F, Konishi Y. The road to advanced glycation end products: A mechanistic perspective. Curr Med Chem 2007; 14: 1653–1671
   PubMed Web of Science ®Google Scholar
• Khalifah RG, Todd P, Booth AA, Yang SX, Mott JD, Hudson BG. Kinetics of nonenzymatic glycation of ribonuclease a leading to advanced glycation end products. paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies. Biochemistry 1996; 35: 4645–4654
   PubMedGoogle Scholar
• Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y. Increased serum levels of advanced glycation end products and diabetic complications. Diabetes Res Clin Pract 1998; 41: 131–137
   PubMed Web of Science ®Google Scholar
• Edelstein D, Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 1992; 41: 26–29
   PubMed Web of Science ®Google Scholar
• Li J, Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the Receptor for Advanced Glycation End products. J Biol Chem 1997; 272: 16498–16506
   PubMed Web of Science ®Google Scholar
• Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T, Luther T, Berentshtein E, Tritschler H, Muller M, et al. Advanced glycation end product-induced activation of NF-KappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997; 46: 1481–1490
   PubMed Web of Science ®Google Scholar
• Lindemann S, Kramer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007; 5(Suppl 1)203–211
   PubMedGoogle Scholar
• Hasegawa Y, Suehiro A, Higasa S, Namba M, Kakishita E. Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus. Thromb Res 2002; 107: 319–323
   PubMed Web of Science ®Google Scholar
• Hangaishi M, Taguchi J, Miyata T, Ikari Y, Togo M, Hashimoto Y, Watanabe T, Kimura S, Kurokawa K, Ohno M. Increased aggregation of human platelets produced by advanced glycation end products in vitro. Biochem Biophys Res Commun 1998; 248: 285–292
   PubMed Web of Science ®Google Scholar
• Alexandru N, Popov D, Sbarcea A, Amuzescu M. Platelet free cytosolic calcium concentration during ageing of type 2 diabetic patients. Platelets 2007; 8: 473–480
   Google Scholar
• Jesty J, Yin W, Perrotta P, Bluestein D. Platelet activation in a circulating flow loop: Combined effects of shear stress and exposure time. Platelets 2003; 4: 143–149
   Google Scholar
• Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation 2004; 109: 78–83
   PubMed Web of Science ®Google Scholar
• Jesty J, Bluestein D. Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: Elimination of the feedback activation of platelets by thrombin. Anal Biochem 1999; 272: 64–70
   PubMed Web of Science ®Google Scholar
• Nagayama H, Inaba M, Okabe R, Emoto M, Ishimura E, Okazaki S, Nishizawa Y. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed Pharmacother 2008; 63: 236–240
   PubMedGoogle Scholar
• Rajagopalan S, Mckay I, Ford I, Bachoo P, Greaves M, Brittenden J. Platelet activation increases with the severity of peripheral arterial disease: Implications for clinical management. J Vasc Surg 2007; 46: 485–490
   PubMedGoogle Scholar
• Haitoglou CS, Tsilibary EC, Brownlee M, Charonis AS. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J Biol Chem 1992; 267: 12404–12407
   PubMed Web of Science ®Google Scholar
• Sajithlal GB, Chithra P, Chandrakasan G. Advanced glycation end products induce crosslinking of collagen in vitro. Biochim Biophys Acta 1998; 1407: 215–224
   PubMed Web of Science ®Google Scholar
• Rao AK, Koike K, Day HJ, Smith JB, Holmsen H. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets. Am J Clin Pathol 1985; 83: 687–696
   PubMedGoogle Scholar
• Bar J, Schoenfeld A, Hod M, Rabinerson D, Marmur A, Brooks GJ, Aviram M. The effects of time interval after venipuncture and of anticoagulation on platelet adhesion and aggregation. Clin Lab Haematol 1996; 18: 281–284
   PubMedGoogle Scholar
• Fallon AM, Dasi LP, Marzec UM, Hanson SR, Yoganathan AP. Procoagulant properties of flow fields in stenotic and expansive orifices. Ann Biomed Eng 2008; 36: 1–13
   PubMedGoogle Scholar